HHL-B:CA:TSX-Harvest Healthcare Leaders Income ETF (CAD)

ETF | Others |

Last Closing

CAD 8.9

Change

0.00 (0.00)%

Market Cap

N/A

Volume

200.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-19 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

N/A

CAD 6.19B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

N/A

CAD 4.87B
PHYS-U:CA Sprott Physical Gold Trust

N/A

CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

+0.45 (+0.71%)

CAD 4.54B
HXT-U:CA Horizons S&P/TSX 60 Index ETF

N/A

CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

+0.18 (+0.85%)

CAD 3.78B
XEQT:CA iShares Core Equity Portfolio

+0.17 (+0.58%)

CAD 3.29B
PSLV-U:CA Sprott Physical Silver Trust

+0.09 (+1.01%)

CAD 3.29B
IGAF:CA IA Clarington Loomis Global Al..

+0.02 (+0.14%)

CAD 3.23B
NSCB:CA NBI Sustainable Canadian Bond ..

+0.09 (+0.42%)

CAD 2.78B

ETFs Containing HHL-B:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 4.22% 63% D 57% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.22% 62% D 55% F
Trailing 12 Months  
Capital Gain 0.56% 34% F 43% F
Dividend Return 0.66% 34% F 9% A-
Total Return 1.22% 33% F 39% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 1.76% 61% D- 50% F
Dividend Return 1.81% 61% D- 44% F
Total Return 0.05% 53% F 11% F
Risk Return Profile  
Volatility (Standard Deviation) 4.17% 80% B- 92% A
Risk Adjusted Return 43.49% 78% C+ 70% C-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:

There is nothing we particularly dislike